NASDAQ:KNSA

Kiniksa Pharmaceuticals . Class A Stock News

Healthcare > Biotechnology

Buy KNSA

*Your capital is at risk

$47.85

+0.93 (+1.98%)

At Close: Jun 03, 2026

Kiniksa Pharmaceuticals International, plc (KNSA) is on the Move, Here's Why the Trend Could be Sustainable

09:51am, Friday, 19'th Sep 2025

If you are looking for stocks that are well positioned to maintain their recent uptrend, Kiniksa Pharmaceuticals International, plc (KNSA) could be a great choice. It is one of the several stocks that

Kiniksa Pharmaceuticals International, Plc (KNSA) Presents At Citi's Biopharma Back To School Conference Transcript

01:57pm, Wednesday, 03'rd Sep 2025

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA ) Citi's Biopharma Back to School Conference September 3, 2025 9:00 AM EDT Company Participants Sanj Patel - CEO & Chairman of the Board Ross Mo

Recent Price Trend in Kiniksa Pharmaceuticals International, plc (KNSA) is Your Friend, Here's Why

09:51am, Wednesday, 03'rd Sep 2025

Kiniksa Pharmaceuticals International, plc (KNSA) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the man

Court Ruling & Tariff Uncertainty: Time to Bet on POST, TME & KNSA?

10:06am, Tuesday, 02'nd Sep 2025

Court ruling on tariffs fuels market jitters, making low-beta picks like Post, Tencent Music and Kiniksa attractive options.

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

04:01pm, Thursday, 28'th Aug 2025

LONDON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in fireside chats at the following investor confer

Wall Street Analysts Believe Kiniksa Pharmaceuticals International, plc (KNSA) Could Rally 26.69%: Here's is How to Trade

10:56am, Monday, 18'th Aug 2025

The consensus price target hints at a 26.7% upside potential for Kiniksa Pharmaceuticals International, plc (KNSA). While empirical research shows that this sought-after metric is hardly effective, an

Kiniksa Pharmaceuticals International, plc (KNSA) Is a Great Choice for 'Trend' Investors, Here's Why

09:50am, Monday, 18'th Aug 2025

5 Stocks With Recent Price Strength Amid Trade & Rate Cut Uncertainties

08:40am, Wednesday, 13'th Aug 2025

MOD, TPC, KNSA, LIF and ESEA are defying trade and rate-cut uncertainty with strong recent price momentum and earnings upgrades.

Kiniksa Pharmaceuticals International, plc (KNSA) Is Up 21.46% in One Week: What You Should Know

01:01pm, Tuesday, 05'th Aug 2025

Does Kiniksa Pharmaceuticals International, plc (KNSA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Just The Tonic: This Medical Stock, A Mutual Fund Darling, Tests Entry Amid 58% Run

01:30pm, Friday, 01'st Aug 2025

A good medical stock can help diversify a portfolio. This particular name is testing a fresh entry as funds pile in.

Why Kiniksa Pharmaceuticals International, plc (KNSA) Might be Well Poised for a Surge

01:20pm, Friday, 01'st Aug 2025

Kiniksa Pharmaceuticals International, plc (KNSA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Does Kiniksa Pharmaceuticals International, plc (KNSA) Have the Potential to Rally 35.96% as Wall Street Analysts Expect?

10:56am, Friday, 01'st Aug 2025

The mean of analysts' price targets for Kiniksa Pharmaceuticals International, plc (KNSA) points to a 36% upside in the stock. While this highly sought-after metric has not proven reasonably effective

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by